Lung cancer is the leading cause of cancer death worldwide, with large variation of the
incidence and mortality across regions. Although the mortality of lung cancer has been …

Lung cancer causes the most cancer deaths in Korea. Although the smoking rate has begun
to decrease, the prevalence of lung cancer is still increasing. We reviewed the national lung …

Background Carboplatin and paclitaxel administered every 3 weeks is standard-of-care first-
line chemotherapy for epithelial ovarian cancer. The Japanese JGOG3016 trial showed a …

Purpose This phase III trial was conducted to test whether the novel vascular disrupting
agent ASA404 (vadimezan), when combined with first-line platinum-based chemotherapy …

Purpose To investigate the efficacy of erlotinib versus docetaxel in previously treated
patients with advanced non–small-cell lung cancer (NSCLC) in an epidermal growth factor …

PURPOSE: This multicenter, randomized, open-label, phase II study (JO19907) compared
the efficacy and safety of first-line carboplatin-paclitaxel (CP) alone with bevacizumab-CP in …

Introduction: Paclitaxel is a microtubule stabilizer that is currently one of the most utilized
chemotherapeutic agents. Its efficacy in breast, uterine, lung and other neoplasms made its …

Background Taxanes, including paclitaxel and docetaxel, are indispensable for treatment of
cancer. Development of toxicity frequently necessitates dose reduction or discontinuation of …

Lung cancer is the leading cause of cancer deaths worldwide. While tobacco exposure is
responsible for the majority of lung cancers, the incidence of lung cancer in never smokers …

This review demonstrates the importance of plants as sources of molecules used in
anticancer therapies. The approach is performed by relating the active molecules to their …